2022, Packaging and Pharmaceutical Manufacturing

Pharmaceutical Manufacturing And Packaging Congress 2022 Connects Pharma Leaders

pharmaphorum

NOVEMBER 29, 2021

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) covers the current state of the pharmaceutical manufacturing and packaging industry. It will take place on June, 20-21, 2022 in Berlin, Germany. It will take place on June, 20-21, 2022 in Berlin, Germany.

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Packaging Pharmaceutical Companies Pharmaceutical Companies

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022)

pharmaphorum

NOVEMBER 30, 2021

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) is held on June, 20-21, 2022 in Berlin, Germany. Pharmaceutical Manufacturing & Packaging Congress provides a networking platform for decision-makers from the pharmaceutical industry to share cases and brand-new solutions in one place.

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Packaging Pharmaceutical Companies Pharmaceutical Companies

Responsible sourcing and manufacturing: Growing towards a sustainable future with Lonza

Express Pharma

JANUARY 17, 2025

The company focuses on utilising packaging to minimise end-of-life waste and employs distribution methods that further reduce environmental impact. As Lonza demonstrates, sustainable practices are not just environmental imperatives but essential components of modern pharmaceutical manufacturing.

Dosage

Dosage Pharmaceutical Manufacturing Packaging Drug Development

IPA questions FAERS data interpretation in the Ohio State University study

Express Pharma

MARCH 12, 2025

IPA also addressed concerns regarding transparency in drug manufacturing locations. It noted that US law requires complete manufacturing addresses to be printed on generic drug packaging and listed in the FDAs Orange Book database.

Generic Medicine

Generic Medicine Process Improvement Dosage Pharmaceutical Manufacturing

Tackling fake pharmaceuticals: an industry united against counterfeit products

European Pharmaceutical Review

JULY 25, 2022

Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. These may be mislabelled or produced in fake packaging and, most dangerously, there is no regulation around their manufacture. But what exactly does this look like? .

Packaging

Packaging Pharmaceutical Manufacturing Online Pharmacies

16th CPHI & PMEC India 2023 redefines pharma landscape

Express Pharma

NOVEMBER 29, 2023

It provides an unparalleled platform for stakeholders to participate in extensive dialogues covering pharma machinery, packaging, analytical instruments, laboratory technologies, equipment, ancillaries, ingredients, and beyond. lakh crores) in the 2022–2023 fiscal year. billion (Rs 2.1

Packaging

Packaging Pharmaceutical Manufacturing

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Green Chemistry in the Synthesis of Pharmaceuticals.

Compounding

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies

Warnings for Japanese pharmaceutical market may lead to more lenient price controls

Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 in 2022 to JPY9.498 trillion ($68.08 Japan is currently the fourth largest market in the world. billion) in total sales in 2021 and is expected to grow 1.1%

Drug Pricing

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing

New IFPMA and EFPIA guidance on use of social media by the pharmaceutical industry

pharmaphorum

OCTOBER 27, 2022

She also advises companies on the boundaries of the ABPI and EFPIA codes of practice, as well as UK and EU legislation, regarding the promotion of medicinal products, including use of social media, packaging and labelling, presence at conferences, use of consultants, and marketing materials.

Communication

Communication Pharmaceutical Manufacturing Packaging Documentation

Warnings for Japanese pharmaceutical market may lead to more lenient price controls

Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 in 2022 to JPY9.498 trillion ($68.08 Japan is currently the fourth largest market in the world. billion) in total sales in 2021 and is expected to grow 1.1%

Drug Pricing

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing

Exclusive Coverage: Global PHT Expo & Summit 2023

PharmaShots

FEBRUARY 27, 2023

Manan Sharma- “as from the technology side I will start with the recently used cases like the government of India has already made it mandatory for around 300 drugs to have their barcode on the packaging to track and trace the information of the drugs. facility for manufacturing biologics in his presentation.

FDA warning letters highlight CAPA concerns

European Pharmaceutical Review

AUGUST 10, 2023

Amidst numerous warning letters distributed by the US Food and Drug Administration (FDA) to pharmaceutical manufacturers in recent months, in July this year, the US regulatory body published its analysis on drug product quality in 2022. In subsequent years, up to 2022, half this number or less were issued.

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Packaging

‘Right shoring’ API production in Europe

Pharmaceutical Technology

MARCH 22, 2023

Only 25% of API production for generic drugs took place in Europe in 2020, according to a November 2022 Medicines for Europe report. Due to the cessation of Russian gas imports following its invasion of Ukraine, electricity prices increased up to tenfold, and raw material costs rose by 50% to 160% in Q3 2022.

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Packaging Communication Diabetes

Higher throughput integrity testing: Defining a modern CCIT system for the demands of serial production

Pharmaceutical Technology

FEBRUARY 9, 2023

Container Closure Integrity Testing (CCIT) is used to evaluate the ability of a pharmaceutical’s primary packaging to protect the sterility of its contents. On a regular basis, pharmaceutical manufacturers are performing CCIT during commercial production to ensure that packaging processes are operating as they should.

Packaging

Packaging Pharmaceutical Manufacturing Communication Pharmaceutical Companies

Pharmacist Digest

Pharmaceutical Manufacturing And Packaging Congress 2022 Connects Pharma Leaders

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022)

Trending Sources

Responsible sourcing and manufacturing: Growing towards a sustainable future with Lonza

IPA questions FAERS data interpretation in the Ohio State University study

Tackling fake pharmaceuticals: an industry united against counterfeit products

16th CPHI & PMEC India 2023 redefines pharma landscape

Building CO2-neutral, defossilised supply chains for chemicals

Warnings for Japanese pharmaceutical market may lead to more lenient price controls

New IFPMA and EFPIA guidance on use of social media by the pharmaceutical industry

Warnings for Japanese pharmaceutical market may lead to more lenient price controls

Exclusive Coverage: Global PHT Expo & Summit 2023

FDA warning letters highlight CAPA concerns

‘Right shoring’ API production in Europe

Higher throughput integrity testing: Defining a modern CCIT system for the demands of serial production

Stay Connected